OppenheimerFunds’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$16.8M Sell
284,778
-74,840
-21% -$4.47M 0.02% 578
2018
Q4
$19M Buy
359,618
+74,248
+26% +$4.08M 0.03% 525
2018
Q3
$17.1M Buy
+285,370
New +$15.6M 0.02% 624
2017
Q1
Sell
-254,730
Closed -$9.19M 1874
2016
Q4
$9.19M Sell
254,730
-1,010
-0.4% -$33.6K 0.01% 770
2016
Q3
$7.64M Buy
+255,740
New +$7.47M 0.01% 773

Other funds holding MEDP

OppenheimerFunds's MEDP Position: Q1 2019 in Review

OppenheimerFunds reduced its Medpace (MEDP) stake by 21% in Q1 2019, selling an estimated $4.47M and leaving 284,778 shares worth $16.8M. The position accounts for 0.02% of the portfolio, ranked #578.

OppenheimerFunds first reported a position in MEDP in Q3 2016 and has held it in 5 quarters since. The position peaked at $19M in Q4 2018. 231 funds tracked by Wall St. Rank hold MEDP as of Q1 2019.

  • OppenheimerFunds held 284,778 shares of Medpace worth $16.8M as of Q1 2019.
  • OppenheimerFunds sold 74,840 Medpace shares in Q1 2019, an estimated $4.47M.
  • Medpace made up 0.02% of OppenheimerFunds's portfolio in Q1 2019, its #578 holding.
  • OppenheimerFunds first reported a position in Medpace in Q3 2016 and has held it in 5 quarters since.
  • OppenheimerFunds's Medpace position peaked at $19M in Q4 2018.
  • 231 funds tracked by Wall St. Rank held Medpace as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.